Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IKZF2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
mRNA | BMF | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | NCOA4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | N4BP2L1 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
mRNA | WHSC1L1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | TAL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | UTP3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | BRD3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | KSR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |